Arkolith/Insider Trading/QNCX/Form 4

Thye Dirk

CEO AND CHIEF MEDICAL OFFICER, DirectorQuince Therapeutics, Inc. (QNCX) · full profile →Form 4 · filed Sep 3, 2024
Net Buying
Open-Market Buys
$107K
Open-Market Sells
$0
Net Open-Market Flow
$107K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 30, 2024Buy(P)77K$0.70$54K844K
Aug 29, 2024Buy(P)78K$0.69$53K767K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-022702) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML